Gupta Ruby, Lakshmy Ramakrishnan, Abraham Ransi Ann, Reddy Kolli Srinath, Jeemon Panniyammakal, Prabhakaran Dorairaj
South Asia Network for Chronic Disease, New Delhi, India.
Center for Chronic Disease Control, New Delhi, India.
Food Nutr Sci. 2013 Sep;4(9A):94-97. doi: 10.4236/fns.2013.49A1015.
High omega-6/omega-3 ratio intake promotes development of many chronic diseases. Secondary prevention studies though have demonstrated a decline in progression of many such diseases after reducing the intake, specific biochemical indices of cardiovascular disease risk markers have not been evaluated. We have evaluated the circulating levels of omega-6/omega-3 ratio and its effect on cardiovascular risk markers in India. Present study was conducted in industrial setting where employees were randomly selected. Data on their demographic characteristics were collected using pre-tested questionnaire. Fasting blood samples were collected from all the participants. Serum was separated and stored at -80°C till the time of analysis. Lipids were estimated using standard kits. Fatty acids in serum were estimated by Gas chromatography. The identified Omega-3 fatty acid included were 18:3 (Alpha-linolenic acid), 20:5 (Eicosapentenoic acid) & 22:6 (Docosahexenoic acid). Among omega-6 included were 18:2 (linoleic acid), 18:3 (gamma-linolenic acid) & 20:4 (Arachidonic acid). Complete data was available for 176 participants (89% males and 11% females) with mean age of 47.23 ± 6.00 years. The bmi of the participants was 24.88 ± 3.43 Kg/m and waist circumference was 91.50 ± 9.56 cm. The median of omega-6/omega-3 ratio in the study population was 36.69 (range: 6.21 - 183.69). The levels of total cholesterol, triglycerides, ldl-cholesterol and cholesterol/hdl ratio and apo B correlated significantly with omega-6/3 ratio. There was no correlation observed with hsCRP and LDL-particle size. A direct relationship of omega-6/omega-3 ratio with dyslipidemia was observed in our study.
高欧米伽-6/欧米伽-3比值的摄入会促进多种慢性疾病的发展。尽管二级预防研究表明,在减少摄入量后,许多此类疾病的进展有所下降,但尚未评估心血管疾病风险标志物的具体生化指标。我们评估了印度人群中循环的欧米伽-6/欧米伽-3比值水平及其对心血管风险标志物的影响。本研究在工业环境中进行,随机选择员工。使用预先测试的问卷收集他们的人口统计学特征数据。从所有参与者中采集空腹血样。分离血清并在-80°C下保存直至分析时。使用标准试剂盒估算血脂。通过气相色谱法估算血清中的脂肪酸。鉴定出的欧米伽-3脂肪酸包括18:3(α-亚麻酸)、20:5(二十碳五烯酸)和22:6(二十二碳六烯酸)。欧米伽-6包括18:2(亚油酸)、18:3(γ-亚麻酸)和20:4(花生四烯酸)。共有176名参与者(89%为男性,11%为女性)的完整数据可用,平均年龄为47.23±6.00岁。参与者的体重指数为24.88±3.43 Kg/m,腰围为91.50±9.56 cm。研究人群中欧米伽-6/欧米伽-3比值的中位数为36.69(范围:6.21 - 183.69)。总胆固醇、甘油三酯、低密度脂蛋白胆固醇和胆固醇/高密度脂蛋白比值以及载脂蛋白B水平与欧米伽-6/3比值显著相关。未观察到与高敏C反应蛋白和低密度脂蛋白颗粒大小的相关性。在我们的研究中观察到欧米伽-6/欧米伽-3比值与血脂异常之间存在直接关系。